
Saving lives with breath aerosol diagnostics

The need
-
Up to 20% of all primary care consultations are due to respiratory infections¹
-
They result in 4 million deaths each year, almost all of them due to infections in the lower respiratory tract causing pneumonia²
-
Lack of good diagnostic solutions are a main reason for poor outcomes and antibiotic overuse
-
Transformative, rapid testing where people first seek care is needed to capture pneumonia early and initiate the right treatment

Our solution
A non-invasive sample-to-answer breath test that reliably detects multiple lower respiratory tract infections in primary care within minutes in three simple steps:
1. Collect

Breathe for
2 minutes
2. Detect

Diagnose
multiple diseases
3. Act

Take the right
action
The impact
-
Saving lives by earlier appropriate antibiotic or antiviral treatment and rapid patient referral
-
Reducing healthcare costs: Avelo's rapid test results help to lower the annual costs of USD 52 billion in Europe alone by keeping patients out of the hospital³
-
Fighting antimicrobial resistance (AMR): Avelo's test differentiates between viral and bacterial infections to assist in antibiotic stewardship and reduce the > 65% unnecessarily prescribed antibiotics in primary care⁴
-
Establishing self-collected breath bioaerosols as a novel diagnostic sample type for new testing solutions
